연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
2781. Pediatric-Type Indolent B-Cell Lymphomas With Overlapping Clinical, Pathologic, and Genetic Features
Sojung Lim 1, Ka Young Lim 1, Jiwon Koh 1, Jeong Mo Bae 1, Hongseok Yun 2, Cheol Lee 1, Young A Kim 3, Jin Ho Paik 4, Yoon Kyung Jeon 1 5
Am J Surg Pathol. 2022 Oct 1;46(10):1397-1406
Link
2780. TCF1+PD-1+ tumour-infiltrating lymphocytes predict a favorable response and prolonged survival after immune checkpoint inhibitor therapy for non-small-cell lung cancer
Jaemoon Koh 1, Sehui Kim 2, Yeon Duk Woo 3, Seung Geun Song 1, Jeemin Yim 4, Bogyeong Han 4, Sojung Lim 4, Hyun Kyung Ahn 5, Seungchan Mun 6, Jung Sun Kim 7, Bhumsuk Keam 7, Young A Kim 8, Se-Hoon Lee 9, Yoon Kyung Jeon 10, Doo Hyun Chung 11
Eur J Cancer. 2022 Oct;174:10-20.
Link
2779. Molecular Classification of Extrapulmonary Neuroendocrine Carcinomas With Emphasis on POU2F3-positive Tuft Cell Carcinoma
Jiwon Koh 1, Haeryoung Kim 1, Kyung Chul Moon 1, Cheol Lee 1, Kyoungbun Lee 1, Han Suk Ryu 1, Kyeong Cheon Jung 1, Yoon Kyung Jeon 1 2
Am J Surg Pathol. 2022 Oct 14.
Link
2778. High tumor hexokinase-2 expression promotes a pro-tumorigenic immune microenvironment by modulating CD8+/regulatory T-cell infiltration
Sehui Kim 1 2, Jaemoon Koh 1, Seung Geun Song 1 3, Jeemin Yim 1, Miso Kim 4, Bhumsuk Keam 4, Young Tae Kim 5 6, Jihun Kim 7, Doo Hyun Chung 1 3, Yoon Kyung Jeon 8 9
BMC Cancer. 2022 Nov 1;22(1):1120
Link
2777. Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes.
Hyeon DY, Nam D, Han Y, Kim DK, Kim G, Kim D, Bae J, Back S, Mun DG, Madar IH, Lee H, Kim SJ, Kim H, Hyun S, Kim CR, Choi SA, Kim YR, Jeong J, Jeon S, Choo YW, Lee KB, Kwon W, Choi S, Goo T, Park T, Suh YA, Kim H, Ku JL, Kim MS, Paek E, Park D, Jung K, Baek SH, Jang JY, Hwang D, Lee SW.
Nat Cancer. 2022 Dec 22.
Link
2776. Oncological outcome of proximal and middle extrahepatic bile duct cancer according to surgical extent (Is hilar resection oncologically acceptable in proximal and middle extrahepatic bile duct cancer?).
Lee M, Jung HS, Cho YJ, Yun WG, Han Y, Kim H, Kwon W, Jang JY.
HPB (Oxford). 2022 Oct 1:S1365-182X(22)01599-4. doi: 10.1016/j.hpb.2022.09.009.
Link
2775. Oncologic Benefits of Neoadjuvant Treatment versus Upfront Surgery in Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis.
Jung, H.-S.; Kim, H.S.; Kang, J.S.; Kang, Y.H.; Sohn, H.J.; Byun, Y.; Han, Y.; Yun, W.-G.; Cho, Y.J.; Lee, M.; Kwon, W.; Jang, J.-Y.
. Cancers 2022, 14, 4360. https://doi.org/10.3390/cancers14184360
Link
2774. Impact of surgery on survival outcomes for Bismuth type IV Klatskin tumors.
Choi YJ, Lee JM, Kang JS, Sohn HJ, Byun Y, Han Y, Kim H, Kwon W, Jang JY.
J Gastrointest Surg. 2022 Jun 9. doi: 10.1007/s11605-022-05293-1.
Link
2773. Can Surgical Resection of Metastatic Lesions Be Beneficial to Pancreatic Ductal Adenocarcinoma Patients with Isolated Lung Metastasis?
Yun WG, Kwon W, Han Y, Sohn HJ, Kim HS, Lee M, Kim H, Thomas AS, Kluger MD, Jang JY.
Cancers (Basel). 2022 Apr 20;14(9):2067.
Link
2772. Prediction of malignancy in Main duct or Mixed-type Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Jung HS, Han Y, Kang JS, Sohn H, Lee M, Lee KB, Kim H, Kwon W, Jang JY.
J Hepatobiliary Pancreat Sci. 2022 Apr 22. Epub ahead of print.
Link